Evidence map›Paper›PMID 42422425›Full record

ArticleFrontiers in endocrinology2026

Comparison of

Daniel A Hescheler, Dogan Atiyat, Kerstin Lorenz, Alexander Heinzel, Philipp Reschke, Frankis G Almaguel, Manuela Petersen, Elisabeth Eppard, Joanna Wybranska, Jan Wuestemann and 1 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel A HeschelerUniversity Hospital Magdeburg, Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, Magdeburg, Germany.
Dogan AtiyatMartin Luther University of Halle Wittenberg Faculty of Medicine, Department of Nuclear Medicine, Halle (Saale), Germany.
Kerstin LorenzMartin Luther University Halle-Wittenberg, Halle (Saale), Department of General, Visceral and Vascular Surgery, Halle (Saale), Germany.
Alexander HeinzelMartin Luther University Halle-Wittenberg, Halle (Saale), Department of Nuclear Medicine, Halle (Saale), Germany.
Philipp ReschkeMartin Luther University Halle-Wittenberg, Halle (Saale), Department of Nuclear Medicine, Halle (Saale), Germany.
Frankis G AlmaguelUniversity Hospital Frankfurt, Department of Radiology, Frankfurt, Germany.
Manuela PetersenLoma Linda University Medical Center, Department of Radiology, Loma Linda, CA, United States.
Elisabeth EppardUniversity Hospital Magdeburg, Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, Magdeburg, Germany.
Joanna WybranskaUniversity Hospital Magdeburg, Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, Magdeburg, Germany.
Jan WuestemannUniversity Hospital Magdeburg, Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, Magdeburg, Germany.
Michael C KreisslUniversity Hospital Magdeburg, Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, Magdeburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Accurate staging is paramount for the effective management of medullary thyroid carcinoma (MTC). Imaging cancer-associated fibroblasts utilizing Gallium-68-labeled fibroblast activation protein inhibitors (FAPI) presents a novel approach for molecular imaging across various cancers, including MTC. This study aimed to compare the diagnostic accuracy of FAP-targeted imaging ( Methods: This retrospective study compared Results: Nine patients (mean age 55 years, range 34-80 years) with 62 lesions were included. Compared to Conclusion: In direct comparison,

Indexed as

Carcinoma, NeuroendocrineDihydroxyphenylalanineGallium RadioisotopesPositron Emission Tomography Computed TomographyThyroid NeoplasmsAdultAgedAged, 80 and overEndopeptidasesFemaleFibroblast Activation Protein AlphaHumansLymphatic MetastasisMaleMiddle AgedQuinolines68Ga-FAPIDihydroxyphenylalanineEndopeptidasesFibroblast Activation Protein Alphafluorodopa F 18Gallium RadioisotopesQuinolinesRadiopharmaceuticalsDOPAFAPImedullary thyroid cancerPETrecurrence

Identifiers

PMID42422425
PMCPMC13342799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.